NCJ Number
310575
Date Published
2025
Length
5 pages
Abstract
This report provides up-to-date information regarding the status of NPS benzodiazepine prevalence and positivity in the United States.
Novel psychoactive substances (NPS), including NPS benzodiazepines, continue to pose great challenges for forensic scientists, clinicians, and public health and safety personnel. NPS benzodiazepines have been implicated in an increasing number of adverse health events, marked by emergency room admissions and death investigations, especially when ingested in combination with opioids. Maintaining a current scope of analysis can be challenging, requiring comprehensive analytical methodologies and reference materials for identification(s). (Publisher abstract provided.)
Date Published: January 1, 2025
Downloads
Similar Publications
- Sex estimation in Filipino crania using metric and nonmetric methods
- Regioisomeric bromodimethoxy benzyl piperazines related to the designer substance 4-bromo-2,5-dimethoxybenzylpiperazine: GC–MS and FTIR analysis
- Incapacitated, Forcible, and Drug/Alcohol-Facilitated Rape in Relation to Binge Drinking, Marijuana Use, and Illicit Drug Use: A National Survey